24 HR nicotine 1.17 MG/HR Transdermal System — RxCUI 2707585
RxNorm drug concept · Semantic clinical drug
RxCUI 2707585
Semantic clinical drug · SCD
● Current RxNorm concept 6 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2707585
Official name24 HR nicotine 1.17 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnicotine 28 MG/Day 24 HR Transdermal Patch; nicotine 28 MG/Day 24HR Transdermal Patch
FDA products mapped6
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nicotine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You need to stop smoking completely from the moment you start the patch — not cut back gradually. Even when you're not wearing it, nicotine stays in your skin and keeps releasing i...
- Do I need to quit smoking completely on day one, or can I cut back gradually while using the patch?
- You can do either — it depends on how your body reacts. If morning cigarette cravings are strong, wearing it for the full 24 hours can help. But if you're getting vivid dreams or h...
- Can I wear the patch overnight, or should I take it off at bedtime?
🕸️ Concept Web — How 24 HR nicotine 1.17 MG/HR Transdermal System Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR nicotine 1.17 MG/HR Transdermal System
RxCUI 2707585 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nicotine
7407IN
-
Nicotine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nicduic
2727284BN
-
Nicduic
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nicotine Transdermal System
1805957SCDF -
Nicotine Topical Product
1158682SCDG -
Nicotine Transdermal Product
1295678SCDG -
Nicotine Transdermal System [Nicduic]
2727288SBDF -
Nicduic Topical Product
2727286SBDG -
Nicduic Transdermal Product
2727287SBDG -
Transdermal System
316987DF -
Topical Product
1151122DFG - +1 more in this family
-
Nicotine Transdermal System
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nicotine 1.17 MG/HR
2707584SCDC -
24 HR nicotine 1.17 MG/HR Transdermal System [Nicduic]
2727295SBD -
Nicotine 1.17 MG/HR [Nicduic]
2727294SBDC
-
Nicotine 1.17 MG/HR
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nicotine 1.17 MG/HR
SCDC · 2707584 -
Nicotine Transdermal System
SCDF · 1805957 -
Nicotine Topical Product
SCDG · 1158682 -
Nicotine Transdermal Product
SCDG · 1295678
Brand-Name Concepts
-
24 HR nicotine 1.17 MG/HR Transdermal System [Nicduic]
SBD · 2727295 -
Nicotine 1.17 MG/HR [Nicduic]
SBDC · 2727294 -
Nicotine Transdermal System [Nicduic]
SBDF · 2727288 -
Nicduic Topical Product
SBDG · 2727286 -
Nicduic Transdermal Product
SBDG · 2727287 -
Nicduic
BN · 2727284
📦 FDA Products & Package NDCs
6 products · 9 package NDCs
9 package NDCs map to RxCUI 2707585 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 83818-0014-01 | 31 PATCH in 1 BOX (83818-014-01) | Elsophie Nicotine Patches Quit | Shenzhen Xinxin Yunhai Technology Co., Ltd. | 2025-06-04 |
| 84778-0086-01 | 20 PATCH in 1 BOX (84778-086-01) / 28 mg in 1 PATCH | Quit smoking patches | Guangzhou Yixin Cross-border E-commerce Co., Ltd. | 2025-09-10 |
| 84778-0087-01 | 20 PATCH in 1 BOX (84778-087-01) / 28 mg in 1 PATCH | QUIT SMOKING NICOTINE PATCHES | Guangzhou Yixin Cross-border E-commerce Co., Ltd. | 2025-09-10 |
| 85835-0001-01 | 15 PATCH in 1 BOX (85835-001-01) | Quit Smoking Nicotine Patches | Shenzhen Paxi Trading Co., Ltd. | 2025-06-30 |
| 85835-0001-02 | 30 PATCH in 1 BOX (85835-001-02) | Quit Smoking Nicotine Patches | Shenzhen Paxi Trading Co., Ltd. | 2025-06-30 |
| 85835-0003-01 | 15 PATCH in 1 BOX (85835-003-01) | NicDuic Quit Smoking Nicotine Patches | Shenzhen Paxi Trading Co., Ltd. | 2025-08-27 |
| 85835-0003-02 | 30 PATCH in 1 BOX (85835-003-02) | NicDuic Quit Smoking Nicotine Patches | Shenzhen Paxi Trading Co., Ltd. | 2025-08-27 |
| 87231-0001-01 | 15 PATCH in 1 BOX (87231-001-01) / 1 PATCH in 1 PATCH | STPSMK QUIT SMOKING NICOTINE PATCHES | Guangzhou Ouruisi Biotechnology Co., Ltd | 2025-11-17 |
| 87231-0001-02 | 30 PATCH in 1 BOX (87231-001-02) / 1 PATCH in 1 PATCH | STPSMK QUIT SMOKING NICOTINE PATCHES | Guangzhou Ouruisi Biotechnology Co., Ltd | 2025-11-17 |
Observed labelers:
Shenzhen Paxi Trading Co., Ltd. (4) ·
Guangzhou Ouruisi Biotechnology Co., Ltd (2) ·
Guangzhou Yixin Cross-border E-commerce Co., Ltd. (2) ·
Shenzhen Xinxin Yunhai Technology Co., Ltd. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.